Related Experiment Video
Updated: Jun 18, 2026

Quantification of Monocyte Chemotactic Activity In Vivo and Characterization of Blood Monocyte Derived Macrophages
Published on: August 12, 2019
Elevated cyclic AMP and PDE4 inhibition induce chemokine expression in human monocyte-derived macrophages
Angie L Hertz1, Andrew T Bender, Kimberly C Smith
1Department of Pharmacology, University of Washington Medical School, Seattle, WA 98195, USA.
Abstract:
Macrophages are central mediators of the innate immune system that can be differentiated from monocytes upon exposure to cytokines. While increased cyclic adenosine monophosphate (cAMP) levels are known to inhibit many lipopolysaccharide-elicited macrophage inflammatory responses, the effects of elevated cAMP on monocyte/macrophage differentiation are not as well understood. We show here that during differentiation, cAMP agonists can cause a large increase in the mRNA and protein levels of several of the pro-inflammatory CXCL and CCL chemokines. The cAMP mediator-exchange protein activated by cAMP (Epac) contributes substantially to the increase in these chemokines. These chemokines are known to play an important role in the regulation of immune responses, particularly regarding the pathogenesis of asthma and chronic obstructive pulmonary disorder. We also found that a selective cAMP-degrading phosphodiesterase (PDE) 4 inhibitor can potentiate the chemokine expression elicited by low-dose forskolin or Prostaglandin E2 (PGE(2)). These data suggest that chemokine receptor antagonists administered in conjunction with a PDE4 inhibitor may improve both the efficacy and safety of PDE4-inhibitor therapy for chronic inflammatory disorders.
Insights
Elevated cyclic adenosine monophosphate (cAMP) levels during monocyte differentiation increase pro-inflammatory chemokines via Epac. PDE4 inhibitors potentiate this effect, suggesting combination therapy for inflammatory disorders.
Area of Science:
- Immunology
- Cell Biology
Background:
- Macrophages are key innate immune cells differentiated from monocytes.
- Elevated cyclic adenosine monophosphate (cAMP) generally inhibits macrophage inflammatory responses.
- The impact of increased cAMP on monocyte/macrophage differentiation remains less understood.
Purpose of the Study:
- To investigate the effect of elevated cAMP on monocyte/macrophage differentiation.
- To identify the role of Epac (cAMP-activated exchange protein) in this process.
- To explore the potential of phosphodiesterase 4 (PDE4) inhibitors in modulating chemokine expression.
Main Methods:
- Monocyte differentiation was induced with cytokine exposure.
- cAMP agonists were used to elevate intracellular cAMP levels.
- mRNA and protein levels of chemokines (CXCL, CCL) were quantified.
- The role of Epac was assessed using specific mediators.
- The effect of a PDE4 inhibitor on chemokine expression was evaluated.
Main Results:
- Elevated cAMP during differentiation significantly increased mRNA and protein levels of pro-inflammatory chemokines (CXCL, CCL).
- Epac was found to substantially contribute to the cAMP-induced increase in chemokine expression.
- A selective PDE4 inhibitor potentiated chemokine expression induced by low-dose forskolin or Prostaglandin E2 (PGE(2)).
Conclusions:
- Increased cAMP during monocyte differentiation promotes the expression of pro-inflammatory chemokines, partly mediated by Epac.
- PDE4 inhibitors can enhance this chemokine response.
- Combination therapy with chemokine receptor antagonists and PDE4 inhibitors may offer improved efficacy and safety for inflammatory diseases like asthma and COPD.
Related Concept Videos
Differentiation of Common Myeloid Progenitor Cells
GPCRs Regulate Adenylyl Cylase Activity
Two...
Intracellular Signaling Cascades
cAMP-dependent Protein Kinase Pathways
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...

